MESOHYAL ORGANIC SILICON

MESOHYAL ORGANIC SILICON is a sterile solution:
- Improves water retention in the skin.
- Reduces the signs of ageing.

- MESOESTETIC
- NAME: MESOHYAL ORGANIC SILICON
- COMPOSITION: Hyaluronic acid 2.5 mg/ml, organic silicon 2.7 mg/5 ml.
- PRESENTATION: 10 x 5 ml.
- INDICATIONS: Solution for regeneration and restructuring of skin tissue.
- INJECTION DEPTH: Intradermal injections .
Techniques: nappage or stitch-by-stitch (depending on the area of application).
- DURATION: 5 sessions every 15 days. After the 5 treatment sessions, maintenance is recommended every 3-6 months.
- USE: Strict medical use.

- Vials: 10 x 5 ml.

Face, neck décolleté, back of the hands, arms, back, chest, abdomen, periumbilical area, hips and thighs.

Hyaluronic acid 2.5 mg/ml, organic silicon 2.7 mg/5 ml.

- Administration only by qualified healthcare professionals with experience in intradermal injections.
- Disinfect the area thoroughly before injection.
- Inject slowly, using point-by-point technique or nappage depending on the area.
- Gently massage the area after injection to distribute the product.
- Inform the patient of possible adverse effects such as swelling, erythema, induration or bruising that may last for several days.
- Store the product between 2 °C and 25 °C, protect it from light and keep it out of the reach of children.
- Avoid use in patients at risk of problematic scarring.
- Monitor the patient in the post-treatment period for any persistent reactions.

MESOHYAL ORGANIC SILICON is contraindicated in the following cases:
- Do not inject directly into blood vessels.
- Do not use on skin with irritation, erythema, inflammation, wounds or burns.
- Auto-immune diseases or use of immunosuppressive therapies.
- Known allergy to any of the ingredients (e.g. hyaluronic acid, peptides, idebenone).
- In patients allergic to acetylsalicylic acid.
- Pregnancy and lactation.
- Active inflammatory skin diseases (e.g. acne, herpes).
- Clotting disorders or use of anticoagulants.
- Skin with poor tolerance to injections (e.g. vascular skin, risk of scarring).

Prevention of ageing. Facial and body skin flaccidity. Primary phase stretch marks and scars.